ARTICLE | Clinical News
Fluticasone propionate/salmeterol MDPI: Phase III data
November 23, 2015 8:00 AM UTC
Top-line data from the double-blind, international Phase III Study FSS-AS-301 in 1,363 adolescent and adult patients with persistent asthma that was symptomatic despite low- or mid-dose inhaled cortic...